JPH0477748B2 - - Google Patents

Info

Publication number
JPH0477748B2
JPH0477748B2 JP15854383A JP15854383A JPH0477748B2 JP H0477748 B2 JPH0477748 B2 JP H0477748B2 JP 15854383 A JP15854383 A JP 15854383A JP 15854383 A JP15854383 A JP 15854383A JP H0477748 B2 JPH0477748 B2 JP H0477748B2
Authority
JP
Japan
Prior art keywords
formula
mol
cyanoimino
residue
ether
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP15854383A
Other languages
Japanese (ja)
Other versions
JPS6051182A (en
Inventor
Dotaro Fujimoto
Giichi Funatsukuri
Masatoshi Sakae
Takeshi Sakai
Shuhei Takamatsu
Masanori Katsurada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujimoto Pharmaceutical Corp
Original Assignee
Fujimoto Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujimoto Pharmaceutical Corp filed Critical Fujimoto Pharmaceutical Corp
Priority to JP15854383A priority Critical patent/JPS6051182A/en
Publication of JPS6051182A publication Critical patent/JPS6051182A/en
Publication of JPH0477748B2 publication Critical patent/JPH0477748B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Thiazole And Isothizaole Compounds (AREA)

Description

【発明の詳細な説明】 本発明は、式〔〕で示される3−置換チアゾ
リジンの製造法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing a 3-substituted thiazolidine represented by the formula [].

〔式中、Rはアルキル、またはアリールを表わ
す〕。
[In the formula, R represents alkyl or aryl].

従来、上記チアゾリジン化合物〔〕は、式: RNHCH2CH2SH で示されるN−置換アミノエタンチオールとホル
ムアルデヒド(HCHO)とを反応させることに
より製造されている。しかしながら、このN−置
換アミノエタンチオールは化学的に不安定である
だけでなく、その製造においては、まず−SHを
適当な保護基で保護し、アミノ基を置換したのち
保護基を取除かなければならない。更にやつかい
なことは、この化合物は二級アミンであつて反応
中に存在する一級アミン、三級アミンとの分離が
極めて難しいことである。
Conventionally, the above thiazolidine compound [] has been produced by reacting N-substituted aminoethanethiol represented by the formula: RNHCH 2 CH 2 SH with formaldehyde (HCHO). However, not only is this N-substituted aminoethanethiol chemically unstable, but its production requires first protecting -SH with an appropriate protecting group, substituting the amino group, and then removing the protecting group. There must be. What is more difficult is that this compound is a secondary amine and is extremely difficult to separate from the primary amine and tertiary amine present during the reaction.

本発明は上記問題を解決したものである。 The present invention solves the above problem.

本発明によれば、式〔〕 〔式中、Rはアルキル、またはアリールを表わ
す〕 で示される2−(N−シアノイミノ)−3−置換チ
アゾリジンを、溶媒中、水素化リチウムアルミニ
ウム(LiAlH4)で還元することにより目的化合
物〔〕が得られる。
According to the invention, the formula [] [In the formula, R represents alkyl or aryl] By reducing the 2-(N-cyanoimino)-3-substituted thiazolidine represented by the following with lithium aluminum hydride (LiAlH 4 ) in a solvent, the target compound [] is obtained.

溶媒は、エーテルやテトラヒドロフランなどの
エーテル系溶媒が好ましい。反応は、0℃〜室温
までの温度において容易に進行する。
The solvent is preferably an ether solvent such as ether or tetrahydrofuran. The reaction readily proceeds at temperatures from 0°C to room temperature.

化合物〔〕におけるRの例として、アルキル
には、メチル、エチル、イソプロピルなど、アリ
ールでは、フエニル、置換フエニルなどが挙げら
れる。
Examples of R in compound [] include methyl, ethyl, isopropyl, etc. for alkyl, and phenyl, substituted phenyl, etc. for aryl.

なお、本発明に使用されるチアゾリジン化合物
〔〕は、式: で示されるN−シアノイミノチアゾリジンと、
式: R−X 〔〕 〔式中、Xはハロゲンを表わす。Rは前記と同
じ〕 で示される化合物とを、溶媒(例えば、ジメチル
ホルムアミド)中、塩基(例えば、水素化ナトリ
ウム、ナトリウムアルコキサイド)の存在下に反
応させることにより容易に得られる。
The thiazolidine compound [] used in the present invention has the formula: N-cyanoiminothiazolidine represented by
Formula: R-X [] [In the formula, X represents halogen. R is the same as above] It can be easily obtained by reacting a compound represented by the following formula in a solvent (for example, dimethylformamide) in the presence of a base (for example, sodium hydride, sodium alkoxide).

実施例 1 3−メチルチアゾリジンの製造: テトラヒドロフラン(THF)500mlに2−(N
−シアノイミノ)−3−メチルチアゾリジン14.1
g(0.1モル)を懸濁させる。0〜5℃に冷却し、
LiALH45g(0.13モル)を徐々に加える。添加
後室温にもどし、一夜攪拌する。反応液に2N水
酸化ナトリウム水溶液を加え過剰のLiAlH4を分
解する。反応液を過しメタノールで洗う。液
を合せて留去し、残渣を水とエーテルで振とうす
る。エーテル相を乾燥留去する。常圧蒸留して、
3−メチルチアゾリジンを得る。収量8.2g
(79.6%)。沸点151〜152℃。
Example 1 Production of 3-methylthiazolidine: 2-(N
-cyanoimino)-3-methylthiazolidine 14.1
g (0.1 mol) are suspended. Cool to 0-5℃,
Gradually add 5g (0.13 mol) of LiALH4 . After addition, return to room temperature and stir overnight. A 2N aqueous sodium hydroxide solution is added to the reaction solution to decompose excess LiAlH 4 . Filter the reaction solution and wash with methanol. The combined liquids are evaporated and the residue is shaken with water and ether. The ether phase is dried and distilled off. Distilled at atmospheric pressure,
3-methylthiazolidine is obtained. Yield 8.2g
(79.6%). Boiling point 151-152℃.

元素分析値(C4H9NS=103.187として) 計算値(%):C46.56,H8.79,N13.57。 Elemental analysis value (as C 4 H 9 NS = 103.187) Calculated value (%): C46.56, H8.79, N13.57.

実測値(%):C46.33,H8.72,N13.29。 Actual value (%): C46.33, H8.72, N13.29.

実施例 2 3−エチルチアゾリジンの製造: THF500mlに2−(N−シアノイミノ)−3−エ
チルチアゾリジン15.5g(0.1モル)を懸濁させ、
0〜5℃に冷却する。これにLiAlH45g(0.13モ
ル)を徐々に加え、添加後室温にもどして一夜攪
拌する。反応液に2N水酸化ナトリウムを加え過
剰のLiAlH4を分解する。反応液を過しメタノ
ールで洗う。液を合せて留去し、残渣と水とエ
ーテルで振とうする。エーテル相を乾燥留去し、
残渣を減圧蒸留して、3−エチルチアゾリジンを
得る。収量10.9g(93%)。沸点45〜47℃(25mm
Hg)。
Example 2 Production of 3-ethylthiazolidine: 15.5 g (0.1 mol) of 2-(N-cyanoimino)-3-ethylthiazolidine was suspended in 500 ml of THF.
Cool to 0-5°C. 5 g (0.13 mol) of LiAlH 4 was gradually added thereto, and after the addition, the mixture was allowed to return to room temperature and stirred overnight. Add 2N sodium hydroxide to the reaction solution to decompose excess LiAlH 4 . Filter the reaction solution and wash with methanol. The combined liquids were evaporated and the residue was shaken with water and ether. Dry distillation of the ether phase;
The residue is distilled under reduced pressure to obtain 3-ethylthiazolidine. Yield 10.9g (93%). Boiling point 45-47℃ (25mm
Hg).

元素分析値(C5H11NS=117.214として) 計算値(%):C51.24,H9.46,N11.95 実測値(%):C51.18,H9.37,N11.84。 Elemental analysis value (as C 5 H 11 NS = 117.214) Calculated value (%): C51.24, H9.46, N11.95 Actual value (%): C51.18, H9.37, N11.84.

実施例 3 3−フエニルチアゾリジンの製造: THF500mlに2−(N−シアノイミノ)−3−フ
エニルチアゾリジン20.3g(0.1モル)を懸濁さ
せ、0〜5℃に冷却してLiAlH45g(0.13モル)
を徐々に加える。添加終了後、室温にもどし一夜
攪拌する。反応液に2N水酸化ナトリウム水溶液
を加えて過剰のLiAlH4を分解する。過しメタ
ノールで洗い、液を合せて留去し、残渣を水と
エタノールで振とうする。エーテル相を乾燥留去
し、残渣を減圧蒸留して3−フエニルチアゾリジ
ンを得る。収量13.1g(79.4%)。沸点159〜161
℃(11mmHg) 元素分析値(C9H11NS=165.259として) 計算値(%):C65.41,H6.71,N8.48 実測値(%):C65.62,H6.78,N8.45。
Example 3 Production of 3-phenylthiazolidine: 20.3 g (0.1 mol) of 2-(N-cyanoimino)-3-phenylthiazolidine was suspended in 500 ml of THF, cooled to 0 to 5°C, and 5 g (0.13 mol) of LiAlH 4 was suspended in 500 ml of THF. mole)
Add gradually. After the addition is complete, the mixture is returned to room temperature and stirred overnight. A 2N aqueous sodium hydroxide solution is added to the reaction solution to decompose excess LiAlH 4 . Wash with filtered methanol, combine and evaporate, and shake the residue with water and ethanol. The ether phase is removed by dry distillation, and the residue is distilled under reduced pressure to obtain 3-phenylthiazolidine. Yield: 13.1g (79.4%). Boiling point 159-161
°C (11mmHg) Elemental analysis value (C 9 H 11 NS = 165.259) Calculated value (%): C65.41, H6.71, N8.48 Actual value (%): C65.62, H6.78, N8. 45.

参考例 1 2−(N−シアノイミノ)−3−メチルチアゾリ
ジンの製造: ジメチルホルムアミド(DMF)30mlに50%水
素化ナトリウム(NaH)1.13g(24ミリモル)
を懸濁させ、0〜5℃の冷却下にN−シアノイミ
ノチアゾリジン3g(24ミリモル)を加える。水
素の発生が止んだら、ヨウ化メチル3.35g(24ミ
リモル)を徐々に滴下する。滴下後、室温にもど
し一夜攪拌する。DMFを減圧留去し、残渣を2N
水酸化ナトリウム水溶液と酢酸エチルで抽出す
る。酢酸エチル相を乾燥留去して2−(N−シア
ノイミノ)−3−メチルチアゾリジンの結晶2.1g
(63%)を得る。融点97〜98℃。
Reference Example 1 Production of 2-(N-cyanoimino)-3-methylthiazolidine: 1.13 g (24 mmol) of 50% sodium hydride (NaH) in 30 ml of dimethylformamide (DMF)
is suspended, and 3 g (24 mmol) of N-cyanoiminothiazolidine is added while cooling at 0-5°C. When hydrogen evolution has stopped, 3.35 g (24 mmol) of methyl iodide is gradually added dropwise. After dropping, the mixture was brought to room temperature and stirred overnight. Distill DMF under reduced pressure and reduce the residue to 2N
Extract with aqueous sodium hydroxide and ethyl acetate. Dry distillation of the ethyl acetate phase yielded 2.1 g of crystals of 2-(N-cyanoimino)-3-methylthiazolidine.
(63%). Melting point 97-98℃.

IR.νmax(Nujol)(cm-1):2186,2154,1590,
1430,1245,1070。
IR.νmax (Nujol) (cm -1 ): 2186, 2154, 1590,
1430, 1245, 1070.

参考例 2 2−(N−シアノイミノ)−3−エチルチアゾリ
ジンの製造: DMF200mlに50%NAH4.8g(0.1モル)を懸
濁し、0〜5℃に冷却してN−シアノイミノチア
ゾリジン12.7g(0.1モル)を徐々に加える。水
素の発生が止んだら、エチルブロマイド10.9g
(0.1モル)を滴下し、滴下終了後室温にもどして
一夜攪拌する。反応液を減圧留去し、残渣に水を
加えると粗結晶が生成する。粗結晶をクロロホル
ムに溶解し、分液後乾燥留去し、エーテルから結
晶化させて2−(N−シアノイミノ)−3−エチル
チアゾリジンを得る。11.0g(71%)。融点82〜
84℃。
Reference Example 2 Production of 2-(N-cyanoimino)-3-ethylthiazolidine: Suspend 4.8g (0.1 mol) of 50% NAH in 200ml of DMF, cool to 0 to 5°C, and prepare 12.7g (0.1 mol) of N-cyanoiminothiazolidine. mol) gradually. When hydrogen generation stops, 10.9g of ethyl bromide
(0.1 mol) was added dropwise, and after the addition was completed, the mixture was returned to room temperature and stirred overnight. The reaction solution was distilled off under reduced pressure, and water was added to the residue to form crude crystals. The crude crystals are dissolved in chloroform, separated, and then evaporated to dryness and crystallized from ether to obtain 2-(N-cyanoimino)-3-ethylthiazolidine. 11.0g (71%). Melting point 82~
84℃.

IR.νmax(Nujol):2200,1450,1320,1240,
1060,785(cm-1)。
IR.νmax (Nujol): 2200, 1450, 1320, 1240,
1060,785 (cm -1 ).

Claims (1)

【特許請求の範囲】 1 式 〔式中、Rは下記と同じ〕 で示される2−(N−シアノイミノ)−3−置換チ
アゾリジンを、溶媒中、水素化リチウムアルミニ
ウムで還元することを特徴とする 式 〔式中、Rはアルキル、またはアリールを表わ
す〕 で示される3−置換チアゾリジンの製造法。
[Claims] 1 formula [In the formula, R is the same as below] A 2-(N-cyanoimino)-3-substituted thiazolidine represented by the following formula is reduced with lithium aluminum hydride in a solvent. [In the formula, R represents alkyl or aryl] A method for producing a 3-substituted thiazolidine represented by the following.
JP15854383A 1983-08-30 1983-08-30 Preparation of 3-substituted thiazolidine Granted JPS6051182A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15854383A JPS6051182A (en) 1983-08-30 1983-08-30 Preparation of 3-substituted thiazolidine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15854383A JPS6051182A (en) 1983-08-30 1983-08-30 Preparation of 3-substituted thiazolidine

Publications (2)

Publication Number Publication Date
JPS6051182A JPS6051182A (en) 1985-03-22
JPH0477748B2 true JPH0477748B2 (en) 1992-12-09

Family

ID=15674000

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15854383A Granted JPS6051182A (en) 1983-08-30 1983-08-30 Preparation of 3-substituted thiazolidine

Country Status (1)

Country Link
JP (1) JPS6051182A (en)

Also Published As

Publication number Publication date
JPS6051182A (en) 1985-03-22

Similar Documents

Publication Publication Date Title
HU187562B (en) Process for the preparation of 3,4-dihydro-2-bracket-1h-bracket closed-imino-quinazolin-3-acetic acid derivatives
JP2836041B2 (en) Novel method for producing 1-phenylimidazoline-2,5-dione derivative
DK161966B (en) PROCESS FOR THE PREPARATION OF 5-AROYLED 1,2-DIHYDRO-3H-PYRROLOOE1,2-AAAPYRROL-1-CARBOXYLIC ACID OR ESTERS OR PHARMACEUTICAL ACCEPTABLE SALTS THEREOF
SE452610B (en) SETTING DIVERSE RACEMIC CIS-1,2-CYCLOPROPANDICARBOXYLIC ACID DERIVATIVES
JPH0477748B2 (en)
JPS6355512B2 (en)
US3133928A (en) Certificate of correction
EP0359474B1 (en) Pyridazinone manufacture
JPH0641066A (en) Production of pyrrole derivative
US2856405A (en) Mecuration products of 1-(2-pyrimidyl)-3-allylurea
JPH08503939A (en) Method for producing α-aryl-γ-butyrolactone
JPS5920676B2 (en) Method for producing a novel pyrimido[4,5-d]pyrimidine derivative
JPH0148267B2 (en)
JPS6169781A (en) Preparation of tri-organotin silatrane derivative
US2266199A (en) Dicyanomethyl carbonate and method of preparing the same
KR800001133B1 (en) Process for preparing 5-sulfamoyl benzoic acid substituted by heterocyclic compound
JPS596856B2 (en) Glycerol
JPS58428B2 (en) Synquina 2-oxo-1,2,3,4-tetrahydropyrido (2,3-D) Pyrimidine
JPS5813551B2 (en) Sinquinapiride (4,3-D) Pyrimidinedione
JPH0413674A (en) Production of dihydrofuranone derivative
JPS5813547B2 (en) Cinquinapiride (2,3-D) Pyrimidinedione
JPH09118657A (en) 4-acylaminophenylacetylene alcohol compound and production of 4-acylaminophenylacetylene compound using the same
JPH0578550B2 (en)
JPH03112966A (en) Production of 3-alkyl-2,6-diaminopyridine
JPS5829310B2 (en) Synquina 4-oxo-1234-tetrahydropyrido (2,3-D) pyrimidine